Latest Research in Hematologic Malignancies and CAR-T Engineering

Top Research Topics in Hematologic Malignancies and CAR-T Engineering

• Acute Myeloid Leukemia Research — 70 papers
• Lymphoma Diagnosis and Treatment — 53 papers
• CAR-T cell therapy research — 38 papers
• Glioma Diagnosis and Treatment — 35 papers
• Acute Lymphoblastic Leukemia research — 31 papers
• Chronic Lymphocytic Leukemia Research — 27 papers
• Chronic Myeloid Leukemia Treatments — 14 papers
• Myeloproliferative Neoplasms: Diagnosis and Treatment — 13 papers
• Cancer Immunotherapy and Biomarkers — 11 papers
• Melanoma and MAPK Pathways — 7 papers

Highest-Cited Papers

1. Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia (1 citations)
2. Consolidation Therapy Based on Mutation Clearance in Acute Myeloid Leukemia (1 citations)
3. Pretreatment transcriptional state carries condition-specific information about future clonal detection in a lineage-traced melanoma line
4. Pretreatment transcriptional state carries condition-specific information about future clonal detection in a lineage-traced melanoma line
5. Anti-thymocyte globulin triggers TNF-dependent cell death in T-cell acute lymphoblastic leukemia
6. Pretreatment transcriptional state carries condition-specific information about future clonal detection in a lineage-traced melanoma line
7. Integrating inheritance model selection, weighted polygenic scoring, and interpretable machine learning for cardiotoxicity risk prediction in pediatric ALL
8. Beyond the blood-brain barrier: humanised mice, the missing link in glioblastoma research
9. Generation of an NG2 targeting bispecific antibody for the induction of T-cell immunity against melanoma
10. Protein 4.1 R Suppresses Melanoma Progression by Inhibiting Glycolysis via the PI3K/AKT/mTOR Pathway
11. Integrating immunophenotyping and morphology in the diagnosis of acute leukemia at the National Oncology Center, Sana'a, Yemen
12. Pretreatment transcriptional state carries condition-specific information about future clonal detection in a lineage-traced melanoma line
13. Immune regulation includes an effector arm: therapeutic implications of phase III IDO/PD-L1 vaccination in melanoma
14. Intensive Chemotherapy and Tyrosine Kinase Inhibitor in Patients with De Novo BCR::ABL1+ Acute Myeloid Leukemia
15. Neurotoxicity and cognitive outcomes in modern therapies for primary central nervous system lymphoma
16. RHOA Deletion Downregulates CD19 and Promotes Dysfunctional Immune Microenvironments in CAR-T Resistant Large B-cell Lymphomas
17. Outcomes of adult patients with Li‐Fraumeni syndrome and myeloid neoplasms
18. A phase IIa study of the anti‐ PD ‐ L1 antibody avelumab in relapsed/refractory PTCL : The AVAIL ‐T trial
19. CAR-T cell-induced cytokine release syndrome is rapidly alleviated by Tripterygium glycosides: A case series and laboratory examination study
20. Therapy‐Associated Lineage Switch and Clonal Evolution in Refractory NUP98 :: NSD1 ‐Rearranged Acute Leukemia

Sub-Regions

• Lymphoma Diagnosis and Treatment — 122 papers
• Glioma Diagnosis and Treatment — 65 papers
• Acute Lymphoblastic Leukemia research — 63 papers
• Acute Myeloid Leukemia Research — 38 papers
• Monoclonal and Polyclonal Antibodies Research — 31 papers
• Chronic Myeloid Leukemia Treatments — 26 papers